Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...

PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces the first close of its ...

Moderate to severe obstructive sleep apnea was associated with significantly higher odds of having neovascular age-related macular degeneration, according to a study published in Clinical & ...

The following is a summary of “Associations between a healthy lifestyle score and retinal neurovascular health,” published in ...

The unique challenges, and need for awareness, of age-related macular degeneration (AMD) is now formally recognized in Canada ...

The company offers year-round educational services on the conditions, using this month in particular to guide patients to ...

Lucentis is FDA-approved for the treatment of patients with wet age-related macular degeneration (AMD), macular edema ...

The 36-week trial was a randomized, double-masked, parallel-group, active-controlled, multicenter evaluating CLS-AX (axitinib ...

Faricimab demonstrated noninferior vision gains and improved anatomical outcomes among patients with diabetic macular edema ...